CheckMyRecalls

Zydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl capsules

Published
28 Jan 2026
Units affected
22,896 bottles
Agency
FDA
Country
United States

The hazard

Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-07

Brand / company
Zydus Pharmaceuticals (USA) Inc
Codes / lots
Lot # S2520304, S2520333, Exp 2/28/2027; S2540186, Exp 4/30/2027
Distribution
US Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 28 Jan 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.